Specificity enchanced bispecific antibody (SEBA) , method of producing the same, and use of the same

TW202631690APending Publication Date: 2026-08-01SYSTIMMUNE INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
SYSTIMMUNE INC
Filing Date
2021-09-22
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071921_001
    Figure TWG2TA001071921_001
  • Figure TWG2TA001071921_002
    Figure TWG2TA001071921_002
  • Figure TWG2TA001071921_003
    Figure TWG2TA001071921_003
Patent Text Reader

Abstract

A bispecific tetravalent antibody having a binding specificity to a human epithelium growth factor receptor (EGFR), comprising, from N terminus to C terminus, a Fab region having a first binding specificity to human EGFR, wherein the Fab region comprises a variable region having an amino acid sequence having at least
Need to check novelty before this filing date? Find Prior Art